Kura Oncology, Inc. (KURA)
NASDAQ: KURA · IEX Real-Time Price · USD
12.03
+0.24 (2.04%)
At close:
Mar 27, 2023, 4:00 PM
12.27
+0.24 (2.00%)
After-hours:
Mar 27, 2023, 7:01 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|
| Selling, General & Admin | 47.05 | 46.54 | 31.5 | 19.65 | 16.1 | 9.65 | 7.96 | 6.09 |
| Research & Development | 92.81 | 84.72 | 60.4 | 47.83 | 46.79 | 26.43 | 16.58 | 13.91 |
| Operating Expenses | 139.87 | 131.26 | 91.9 | 67.48 | 62.88 | 36.08 | 24.54 | 19.99 |
| Operating Income | -139.87 | -131.26 | -91.9 | -67.48 | -62.88 | -36.08 | -24.54 | -19.99 |
| Interest Expense / Income | 0.23 | 0.41 | 0.58 | 0.58 | 0.97 | 0.89 | 0.58 | 0.09 |
| Other Expense / Income | -4.25 | -1.21 | -2.85 | -4.92 | -3.41 | -1.53 | 2.45 | 2.54 |
| Pretax Income | -135.84 | -130.47 | -89.63 | -63.14 | -60.45 | -35.43 | -27.56 | -22.63 |
| Net Income | -135.84 | -130.47 | -89.63 | -63.14 | -60.45 | -35.43 | -27.56 | -22.63 |
| Shares Outstanding (Basic) | 67 | 66 | 53 | 42 | 35 | 23 | 19 | 10 |
| Shares Outstanding (Diluted) | 67 | 66 | 53 | 42 | 35 | 23 | 19 | 10 |
| Shares Change | 0.96% | 25.01% | 26.54% | 19.20% | 51.44% | 24.26% | 88.27% | - |
| EPS (Basic) | -2.03 | -1.97 | -1.69 | -1.51 | -1.72 | -1.52 | -1.47 | -2.28 |
| EPS (Diluted) | -2.03 | -1.97 | -1.69 | -1.51 | -1.72 | -1.52 | -1.47 | -2.28 |
| Free Cash Flow Per Share | -1.65 | -1.59 | -1.36 | -1.30 | -1.38 | -1.22 | -1.35 | -1.81 |
| EBITDA | -134.85 | -129.49 | -88.85 | -62.56 | -59.47 | -34.52 | -26.95 | -22.52 |
| Depreciation & Amortization | 0.76 | 0.56 | 0.19 | 0 | 0.01 | 0.03 | 0.03 | 0.02 |
| EBIT | -135.61 | -130.05 | -89.05 | -62.56 | -59.48 | -34.55 | -26.98 | -22.54 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).